Microdosing mushroom sweet treats are recalled in US after six hospital admissions and two potential deaths

All products of a brand of microdosing, mushroom infused confectionery called Diamond Shruumz that are available in the US have been recalled and withdrawn from sale after they were linked to 145 illnesses across 29 states, including 59 hospital admissions and two potential deaths.Diamond Shruumz produces a range of chocolate bars, cones, and gummies that it markets as “an artisan treat for the alternative set.” The confectionery contains a “primo proprietary blend of nootropic and functional mushrooms,” which the company claims are mushrooms with compounds that can improve cognitive function.1The products are sold through the Diamond Shruumz online store, at vape shops, and by retailers selling hemp derived products such as cannabidiol (CBD) or delta 8 tetrahydrocannabinol (delta 8 THC).The US Food and Drug Administration (FDA) became aware of a problem with Diamond Shruumz chocolate bars in June after eight people became ill and six were admitted to hospital, prompting…
Read Original Article: Microdosing mushroom sweet treats are recalled in US after six hospital admissions and two potential deaths »